Clinical trial
Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke
NCT00147602 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00147602 |
|---|---|
| Title | Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke |
| Official title | A Double-Blind, Randomized, Placebo- Controlled Study Of Atorvastatin As Prevention Of Cerebrovascular Events In Patients With A Previous Transient Ischemic Attack (TIA) Or Stroke |
| Acronym | SPARCL |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cardiovascular Disease |
| Intervention type | Drug |
| Interventions | atorvastatin |
| Enrollment | 4,732 |
| Start date | Nov 1, 1998 |
| Completion | Nov 1, 2005 |
| First posted | Sep 7, 2005 |
| Last update posted | Apr 22, 2015 |
| Countries | Australia, Austria, Belgium, Brazil, Chile, Czechia, Denmark, Finland, France, Germany, Greece, Israel and 13 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: